ArticleThe Lancet. Digital health2022
Revising the atherosclerotic cardiovascular disease calculator without race.
Article in The Lancet. Digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Sex Differences in Self-Rated Health and Cardiovascular Disease Events.JAMA network open · 2026Article
- Strengths and Weakness of the Atherosclerotic Cardiovascular Risk Calculation: A Qualitative Study.Journal of the American Board of Family Medicine : JABFM · 2025Article
- What Is Fair? Defining Fairness in Machine Learning for Health.Statistics in medicine · 2025Review
- Racial Bias in Clinical and Population Health Algorithms: A Critical Review of Current Debates.Annual review of public health · 2025Review
- Severity of diastolic dysfunction predicts myocardial infarction.International journal of cardiology. Heart & vasculature · 2024Article
- The Construction and Meaning of Race Within Hypertension Guidelines: A Systematic Scoping Review.Journal of general internal medicine · 2024Article
- Collecting Sociodemographic Data in Pediatric Emergency Research: A Working Group Consensus.Pediatrics · 2024Article
- Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool.AJPM focus · 2024Article
- The C2DREAM framework: Investigating the structural mechanisms undergirding racial health inequities.Journal of clinical and translational science · 2024Article
- Race as a Component of Cardiovascular Disease Risk Prediction Algorithms.Current cardiology reports · 2023Review
- Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States.Annals of internal medicine · 2023Article
- An Anti-Racism and Equity Initiative Improves Residency Educational Conferences.Journal of graduate medical education · 2023Article
- Social determinants of racial health inequities.The Lancet. Public health · 2023Article
- Clinical utility gains from incorporating comorbidity and geographic location information into risk estimation equations for atherosclerotic cardiovascular disease.Journal of the American Medical Informatics Association : JAMIA · 2023Article
- Getting Under the Skin: Race-Based Guidelines and the Pursuit of Pharmacoequity.Journal of general internal medicine · 2022Article
- Achieving equity through science and integrity: dismantling race-based medicine.Pediatric research · 2022Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34952675What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.